A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Clinical trial NCT07075185 · RECRUITING

Trial details

NCT number: NCT07075185
Sponsor: Kelonia Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse Myeloma Multiple Multiple Myeloma Progression Neoplasms by Histologic Type Neoplasm Hemostatic Disorders Vascular Disorder Paraproteinemias Blood Protein Disorders Hematologic Disease and Disorders Lymphoproliferative Disorders Immunoproliferative Disorders

Start date: 2025-07-16
Primary completion: 2027-03-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.